US Patent 11618787 Methods of treating high risk multiple myeloma
Patent 11618787 was granted and assigned to Janssen Biotech on April, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11618787 Methods of treating high risk multiple myeloma
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.